Aclaris Therapeutics (NASDAQ:ACRS) used an H.C. Wainwright inflammatory skin diseases conference fireside chat to outline development plans and differentiation points for its lead biologic candidate, ATI-052, and to provide updates on its small-molecule pipeline.
ATI-052: bispecific approach and ea
Source link
Hello Investors, This is my first post here so be gentle. What are your thoughts on MXI – Maxitrans Industries, for the next 12 months. I like this stock because: 1. The organisation has had a rough year last year, however the new acquisations and issues that have been doing badly have been addressed. 2….
Overall Analysis Bitcoin continues to move within a sideways zone, showing strength on the upside. The previous swing is only 300 points away from its all-time high. Ethereum is slowly rallying upward, with high volatility evident in its price movement. Bitcoin Chart Analysis BTC/USD 15-Minute Chart (Source: TradingView) On the October 30, 2024 trading session,…
The Private Market's Burgeoning Influence On MLP Valuations Source link
Wishing readers on the auspicious occasion of Ganesh Chaturthi Some stuff I am reading today morning: Trump’s 50% tariffs kick in (CNBC) 3 Ways Modi is planning to beat Trump pain (FE) Export units across India halt production (Rediff) SC orders SIT probe into Reliance’s Vantara (BW) Can GST 2.0 spark a growth boom? (ML)…
The Fed acted. Investors re-acted. MarketWatch: ‘U.S. stocks roared higher Thursday, with the Dow Jones Industrial Average topping the 42,000 milestone for the first time and the S&P 500 also surging to a record close, a day after Federal Reserve Chair Jerome Powell repeatedly used variations on the word “recalibrate” to describe the decision to…
November 28, 2024November 28, 2024 On Thursday, South Korea’s central bank lowered its key policy rate for the second month, citing slower-than-expected economic growth. The Bank of Korea cut its benchmark interest rate by 0.25 percentage points to 3%, marking the second consecutive month of rate cuts. The bank…